TALLC (Drug Discovery) Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 1

TALLC (Drug Discovery) General Information

Description

Developer of ophthalmology medicines intended to focus on the unmet needs of patients with corneal and retinal conditions. The company's medicines are a unique combination of NCE drugs and enabling technologies that can improve outcomes for the orphan indication while also addressing the needs of those with presbyopia or suffering from the dry-eye syndrome, enabling keratoconus patients to treat acute and chronic conditions in the eye.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 500 Cartier Boulevard
  • West
  • Laval, Quebec H7V 5B7
  • Canada
+1 (514)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 500 Cartier Boulevard
  • West
  • Laval, Quebec H7V 5B7
  • Canada
+1 (514)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TALLC (Drug Discovery) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TALLC (Drug Discovery)‘s full profile, request access.

Request a free trial

TALLC (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TALLC (Drug Discovery) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TALLC (Drug Discovery)‘s full profile, request access.

Request a free trial

TALLC (Drug Discovery) FAQs

  • When was TALLC (Drug Discovery) founded?

    TALLC (Drug Discovery) was founded in 2020.

  • Where is TALLC (Drug Discovery) headquartered?

    TALLC (Drug Discovery) is headquartered in Laval, Canada.

  • What is the size of TALLC (Drug Discovery)?

    TALLC (Drug Discovery) has 7 total employees.

  • What industry is TALLC (Drug Discovery) in?

    TALLC (Drug Discovery)’s primary industry is Drug Discovery.

  • Is TALLC (Drug Discovery) a private or public company?

    TALLC (Drug Discovery) is a Private company.

  • What is TALLC (Drug Discovery)’s current revenue?

    The current revenue for TALLC (Drug Discovery) is .

  • Who are TALLC (Drug Discovery)’s investors?

    Altus Formulation (Other Pharmaceuticals and Biotechnology) and Tetra Bio-Pharma have invested in TALLC (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process